Molecular Mechanisms of HIV Entry

被引:162
作者
Wilen, Craig B. [1 ]
Tilton, John C. [1 ]
Doms, Robert W. [1 ]
机构
[1] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA
来源
VIRAL MOLECULAR MACHINES | 2012年 / 726卷
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; ENVELOPE GLYCOPROTEIN TRIMERS; CCR5; MONOCLONAL-ANTIBODY; DEFICIENCY SYNDROME AIDS; RECOMBINANT SOLUBLE CD4; CHEMOKINE RECEPTOR GENE; AMINO-TERMINAL DOMAIN; DC-SIGN; DISEASE PROGRESSION; TYROSINE SULFATION;
D O I
10.1007/978-1-4614-0980-9_10
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Human immunodeficiency virus (HIV) entry is a complex and intricate process that facilitates delivery of the viral genome to the host cell. The only viral surface protein, Envelope (Env), is composed of a trimer of gp120 and gp41 heterodimers. It is essentially a fusion machine cloaked in a shroud of carbohydrate structures and variable loops of amino acids that enable it to evade the humoral immune response. For entry to occur gp120 sequentially engages the host protein CD4 and then one of two chemokine coreceptors, either CCR5 or CXCR4. CD4 binding facilitates exposure and formation of the coreceptor-binding site, and coreceptor binding then triggers the membrane fusion machinery in the gp41 subunit. Our understanding of HIV entry has led to the development of successful small molecule inhibitors for the clinical treatment of HIV infection as well as insights into viral tropism and pathogenesis.
引用
收藏
页码:223 / 242
页数:20
相关论文
共 137 条
[1]   CC CKRS: A RANTES, MIP-1 alpha, MIP-1 beta receptor as a fusion cofactor for macrophage-tropic HIV-1 [J].
Alkhatib, G ;
Combadiere, C ;
Broder, CC ;
Feng, Y ;
Kennedy, PE ;
Murphy, PM ;
Berger, EA .
SCIENCE, 1996, 272 (5270) :1955-1958
[2]   CC chemokine receptor 5-mediated signaling and HIV-1 co-receptor activity share common structural determinants - Critical residues in the third extracellular loop support HIV-1 fusion [J].
Alkhatib, G ;
Ahuja, SS ;
Light, D ;
Mummidi, S ;
Berger, EA ;
Ahuja, SK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (32) :19771-19776
[3]  
[Anonymous], AIDS EP UPD DEC 2009
[4]  
[Anonymous], 2009, AIDS PATIENT CARE ST, V23, P987
[5]   A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity [J].
Baba, M ;
Nishimura, O ;
Kanzaki, N ;
Okamoto, M ;
Sawada, H ;
Iizawa, Y ;
Shiraishi, M ;
Aramaki, Y ;
Okonogi, K ;
Ogawa, Y ;
Meguro, K ;
Fujino, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (10) :5698-5703
[6]   The role of DC-SIGN and DC-SIGNR in HIV and SIV attachment, infection, and transmission [J].
Baribaud, F ;
Pöhlmann, S ;
Doms, RW .
VIROLOGY, 2001, 286 (01) :1-6
[7]   ISOLATION OF A T-LYMPHOTROPIC RETROVIRUS FROM A PATIENT AT RISK FOR ACQUIRED IMMUNE-DEFICIENCY SYNDROME (AIDS) [J].
BARRESINOUSSI, F ;
CHERMANN, JC ;
REY, F ;
NUGEYRE, MT ;
CHAMARET, S ;
GRUEST, J ;
DAUGUET, C ;
AXLERBLIN, C ;
VEZINETBRUN, F ;
ROUZIOUX, C ;
ROZENBAUM, W ;
MONTAGNIER, L .
SCIENCE, 1983, 220 (4599) :868-871
[8]   Two HIV-1 Variants Resistant to Small Molecule CCR5 Inhibitors Differ in How They Use CCR5 for Entry [J].
Berro, Reem ;
Sanders, Rogier W. ;
Lu, Min ;
Klasse, Per J. ;
Moore, John P. .
PLOS PATHOGENS, 2009, 5 (08)
[9]   CCR5 and HIV infection [J].
Blanpain, C ;
Libert, F ;
Vassart, G ;
Parmentier, M .
RECEPTORS & CHANNELS, 2002, 8 (01) :19-31
[10]   A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1) [J].
Bleul, CC ;
Fuhlbrigge, RC ;
Casasnovas, JM ;
Aiuti, A ;
Springer, TA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (03) :1101-1109